The relationship between p53, c-myc product expression and clinicopathological parameters in primary breast carcinomas

J Bártková, B Vojtĕsek, J Lukás, J Bártek, D P Lane, C A Midgley, A Rejthar, Z Stasková, J Kovarík, J V Gannon, Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies. Oncogene. ,vol. 6, pp. 1699- 1703 ,(1991)

C. A. Purdie, C. C. Bird, J. O'Grady, A. H. Wyllie, J. Piris, p53 expression in colorectal tumors. American Journal of Pathology. ,vol. 138, pp. 807- 813 ,(1991)

Frederick C. Koerner, Dennis L. Panicali, Steven J. Skates, Ann D. Thor, Sara J. McKenzie, Susan M. Edgerton, Paula J. Marks, Howard J. Fingert, William C. Wood, Laurent H. Schwartz, Samuel Yin, Analysis of c-erbB-2 Expression in Breast Carcinomas with Clinical Follow-up Cancer Research. ,vol. 49, pp. 7147- 7152 ,(1989)

Philippe Jeanteur, Charles Theillet, Laura Spinardi, Joelle Simony-Lafontaine, Raoul Mazars, Meryem BenCheikh, p53 Mutations occur in aggressive breast cancer Cancer Research. ,vol. 52, pp. 3918- 3923 ,(1992)

Elisabeth Ralfkiaer, Jonathan R. Stretch, David P. Lane, Kevin C. Gatter, Adrian L. Harris, Expression of mutant p53 in melanoma. Cancer Research. ,vol. 51, pp. 5976- 5979 ,(1991)

Amanda H. McCann, Peter A. Dervan, Desmond N. Carney, Brendan M. J. Tobin, Myra O'Regan, Mary B. Codd, William J. Gullick, Prognostic significance of c-erbB-2 and estrogen receptor status in human breast cancer. Cancer Research. ,vol. 51, pp. 3296- 3303 ,(1991)

James V. Watson, Karol Sikora, Gerard I. Evan, A simultaneous flow cytometric assay for c-myc oncoprotein and DNA in nuclei from paraffin embedded material Journal of Immunological Methods. ,vol. 83, pp. 179- 192 ,(1985) , 10.1016/0022-1759(85)90071-7

J. L. Ostrowski, A. Sawan, L. Henry, C. Wright, J. A. Henry, C. Hennessy, T. J. W. Lennard, B. Angus, C. H. W. Horne, p53 expression in human breast cancer related to survival and prognostic factors: an immunohistochemical study. The Journal of Pathology. ,vol. 164, pp. 75- 81 ,(1991) , 10.1002/PATH.1711640113

Franco Rilke, Maria Ines Colnaghi, Natale Cascinelli, Salvatore Andreola, Maria Teresa Baldini, Rosaria Bufalino, Giuseppe Della Porta, Sylvie Ménard, Marco A. Pierotti, Alessandro Testori, Prognostic significance of HER-2/NEU expression in breast cancer and its relationship to other prognostic factors International Journal of Cancer. ,vol. 49, pp. 44- 49 ,(1991) , 10.1002/IJC.2910490109

Jiří Bártek, Jiřina Bártková, Bořivoj Vojtěšek, Zdenka Stašková, Aleš Rejthar, Jan Kovařík, David P Lane, None, Patterns of expression of the p53 tumour suppressor in human breast tissues and tumours in situ and in vitro. International Journal of Cancer. ,vol. 46, pp. 839- 844 ,(1990) , 10.1002/IJC.2910460515